We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
CME Group
CME
$95.7B
| $12.9M | 0.03% |
76,470
+32,348
| +73% | +$5.62M |
|
302
Moody's
MCO
$83.7B
| $12.8M | 0.03% |
45,777
+68
| +0.1% | +$18.6K |
|
303
Organon & Co
OGN
$3.56B
| $12.7M | 0.03% |
456,242
+42,464
| +10% | +$1.09M |
|
304
Southern Copper
SCCO
$146B
| $12.6M | 0.03% |
224,424
+152,440
| +212% | +$7.78M |
|
305
Clorox
CLX
$11.9B
| $12.5M | 0.03% |
88,947
+40,821
| +85% | +$5.79M |
|
306
Public Service Enterprise Group
PEG
$38.2B
| $12.4M | 0.03% |
202,022
+27,563
| +16% | +$1.6M |
|
307
VanEck IG Floating Rate ETF
FLTR
$2.97B
| $12.3M | 0.03% |
495,100
| – | – |
|
308
McEwen Inc
MUX
$1.07B
| $12.3M | 0.03% |
2,090,754
+48,333
| +2% | +$225K |
|
|
MRSH
309
Marsh
MRSH
$92B
| $12M | 0.03% |
72,713
+3,012
| +4% | +$493K |
|
310
Intuitive Surgical
ISRG
$135B
| $12M | 0.03% |
45,103
-1,366
| -3% | -$333K |
|
|
GFLU
311
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $12M | 0.03% |
184,871
+2,200
| +1% | +$134K |
|
|
CTLT
312
DELISTED
CATALENT, INC.
CTLT
| $11.9M | 0.03% |
264,103
+57,088
| +28% | +$3.1M |
|
313
Nucor
NUE
$59.5B
| $11.9M | 0.03% |
90,068
-1,642
| -2% | -$223K |
|
314
American Electric Power
AEP
$69.9B
| $11.8M | 0.03% |
123,788
+19,326
| +19% | +$1.76M |
|
315
Sempra
SRE
$57.3B
| $11.7M | 0.03% |
151,480
+23,650
| +19% | +$1.83M |
|
316
Welltower
WELL
$168B
| $11.7M | 0.03% |
177,881
+18,783
| +12% | +$1.21M |
|
317
Rio Tinto
RIO
$156B
| $11.6M | 0.03% |
163,092
-17,531
| -10% | -$1.1M |
|
|
SCHW
318
Charles Schwab
SCHW
$184B
| $11.2M | 0.03% |
134,000
-1,334,660
| -91% | -$104M |
|
319
Repligen
RGEN
$8.3B
| $11M | 0.03% |
65,013
+16,660
| +34% | +$3.02M |
|
320
Nuveen Municipal Credit Income Fund
NZF
$2.39B
| $11M | 0.03% |
908,900
+149,774
| +20% | +$1.73M |
|
321
Starbucks
SBUX
$118B
| $10.9M | 0.03% |
110,281
-2,730
| -2% | -$258K |
|
322
PG&E
PCG
$38.4B
| $10.9M | 0.03% |
672,047
+33,321
| +5% | +$504K |
|
323
CVS Health
CVS
$134B
| $10.8M | 0.03% |
115,945
+7,349
| +7% | +$709K |
|
324
Kinder Morgan
KMI
$69.9B
| $10.8M | 0.03% |
595,118
+45,020
| +8% | +$810K |
|
325
John Wiley & Sons Class A
WLY
$2.7B
| $10.6M | 0.03% |
265,669
+18,894
| +8% | +$791K |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.